JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area ubiquitination proteasome ubiquitination'

Search results for: 'research area ubiquitination proteasome ubiquitination'

A4412 MDL 28170

Target: Cathepsins|Calpains

Summary: Calpain and cathepsin B inhibitor, selective

insoluble in H2O; ≥16.75 mg/mL
A3791 Saquinavir mesylate

Summary: HIV Protease Inhibitor
A8204 Lopinavir

Summary: HIV protease inhibitor,highly potent

≥31.45 mg/mL
A8201 Amprenavir (agenerase)

Summary: HIV-1 protease inhibitor
A3253 BMS-626529

2 Citation

Target: HIV-1 gp120

Summary: HIV-1 attachment inhibitor

insoluble in H2O; insoluble in EtOH; ≥1.48 mg/mL
A8205 Atazanavir

1 Citation

Summary: HIV protease inhibitor,highly potent

≥28.6 mg/mL
A8200 DAPT (GSI-IX)

6 Citation

Summary: γ-secretase inhibitor,potent and specific

≥21.62 mg/mL
A4071 Fluorouracil (Adrucil)

3 Citation

Target: Thymidylate Synthase

Summary: Antitumor agent;inhibitor of thymidylate synthase

insoluble in EtOH; ≥10.04 mg/mL
A8813 NSC697923

Target: Ub-conjugating enzyme (E2) complex

Summary: Inhibitor of E2 complex Ubc13-Uev1A,cell permeable and selective

insoluble in H2O; insoluble in EtOH; ≥26 mg/mL
B6026 VR23

Target: Proteasome

Summary: proteasome inhibitor

insoluble in EtOH; insoluble in H2O; ≥45.55 mg/mL